Literature DB >> 759206

The effect of clonidine on centrally and peripherally evoked submaxillary salivation.

G J Green, H Wilson, M S Yates.   

Abstract

In anaesthetised cats, clonidine (10 microgram/kg, i.v.) produced a 60% reduction in submaxillary salivation induced by brain stem stimulation at 10 and 15 Hz and reductions of 35 and 15% in salivation evoked by chorda tympani nerve stimulation at 5 and 15 Hz respectively. Pretreatment with clonidine (20 microgram/kg/day, orally) for 28 days reduced peripherally evoked salivation by 45%. These results suggest that both central and peripheral mechanisms are involved in the diminished salivation produced by clonidine, and the reduction on peripheral stimulation may reflect the presence of presynaptic alpha-adrenoceptors inhibiting cholinergic transmission.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 759206     DOI: 10.1016/0014-2999(79)90136-5

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

Review 1.  Drugs interacting with alpha adrenoceptors.

Authors:  P A van Zwieten
Journal:  Cardiovasc Drugs Ther       Date:  1989-04       Impact factor: 3.727

2.  Effects of imidazoline antihypertensive drugs on sympathetic tone and noradrenaline release in the prefrontal cortex.

Authors:  B Szabo; T Fritz; K Wedzony
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

3.  Effects of yohimbine on submaxillary salivation in dogs.

Authors:  P Montastruc; M Berlan; J L Montastruc
Journal:  Br J Pharmacol       Date:  1989-09       Impact factor: 8.739

4.  Yohimbine increases submaxillary kallikrein release into the saliva in dogs: evidence for alpha 2-adrenoceptor-mediated inhibition of cholinergic pathways.

Authors:  J P Girolami; J L Bascands; C Pécher; M Berlan; J L Montastruc; P Montastruc
Journal:  Br J Pharmacol       Date:  1991-02       Impact factor: 8.739

5.  Does preoperative oral clonidine inhibit salivary secretion during general anesthesia?

Authors:  R Numazawa; T Mayumi; O Kemmotsu
Journal:  J Anesth       Date:  1993-07       Impact factor: 2.078

6.  Sedative and cardiovascular effects of medetomidine, a novel selective alpha 2-adrenoceptor agonist, in healthy volunteers.

Authors:  M Scheinin; A Kallio; M Koulu; J Viikari; H Scheinin
Journal:  Br J Clin Pharmacol       Date:  1987-10       Impact factor: 4.335

7.  Pharmacological effects and pharmacokinetics of atipamezole, a novel alpha 2-adrenoceptor antagonist--a randomized, double-blind cross-over study in healthy male volunteers.

Authors:  S Karhuvaara; A Kallio; M Scheinin; M Anttila; J S Salonen; H Scheinin
Journal:  Br J Clin Pharmacol       Date:  1990-07       Impact factor: 4.335

8.  Influence of clonidine on experimental hypertension induced by cholinergic stimulation.

Authors:  J J Buccafusco; S Spector
Journal:  Experientia       Date:  1980-06-15

9.  A novel mechanism of action for hypertension control: moxonidine as a selective I1-imidazoline agonist.

Authors:  P Ernsberger; M A Haxhiu; L M Graff; L A Collins; I Dreshaj; D L Grove; M E Graves; S G Schäfer; M O Christen
Journal:  Cardiovasc Drugs Ther       Date:  1994-03       Impact factor: 3.727

10.  Clonidine inhibits salivary secretion by activation of postsynaptic alpha 2-receptors.

Authors:  M D Kaniucki; F J Stefano; C J Perec
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-07       Impact factor: 3.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.